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BACKGROUND: This study explored differences in sexual activity, function, and concerns between cancer survivors and cancer-free
controls in a population-based study. METHODS: The data were from 2982 men and 3708 women who were 50 years old or older
and were participating in the English Longitudinal Study of Ageing. Sexual well-being was assessed with the Sexual Relationships and
Activities Questionnaire, and cancer diagnoses were self-reported. RESULTS: There were no differences between cancer survivors
and controls in levels of sexual activity (76.0% vs 78.5% for men and 58.2% vs 55.5% for women) or sexual function. Men and women
with cancer diagnoses were more dissatisfied with their sex lives than controls (age-adjusted percentages: 30.9% vs 19.8% for men
[P5.023] and 18.2% vs 11.8% for women [P5.034]), and women with cancer were more concerned about levels of sexual desire
(10.2% vs 7.1%; P5.006). Women diagnosed<5 years ago were more likely to report difficulty with becoming aroused (55.4% vs
31.8%; P5.016) and achieving orgasm (60.6% vs 28.3%; P< .001) and were more concerned about sexual desire (14.8% vs 7.1%;
P5.007) and orgasmic experience (17.6% vs 7.1%; P5.042) than controls, but there were no differences in men. CONCLUSIONS:
Self-reports of sexual activity and functioning in older people with cancer are broadly comparable to age-matched, cancer-free
controls. There is a need to identify the causes of sexual dissatisfaction among long-term cancer survivors despite apparently normal
levels of sexual activity and function for their age. The development of interventions addressing low sexual desire and problems with
sexual functioning in women is also important and may be particularly relevant for cancer survivors after treatment. Cancer
2016;000:000–000. VC 2016 The Authors. Cancer published by Wiley Periodicals, Inc. on behalf of American Cancer Society. This is an
open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction
in any medium, provided the original work is properly cited.
KEYWORDS: cancer, sex, sexual activity, sexual concern, sexual function..
INTRODUCTION
Almost 70% of people diagnosed with cancer in the United States survive for at least 5 years,1 and half of people diagnosed
with cancer in the United Kingdom are now expected to survive at least 10 years.2 Although treatment of the cancer is the
primary clinical goal, ensuring the best possible quality of life after treatment is important, and this is increasingly so with
high levels of survivorship. Preservation of sexual function is a key component of quality of life, yet it remains one of the
“unmet needs” commonly reported by cancer survivors.3
Cancer is generally a disease of later life, with more than half of cases (53%) diagnosed in people aged 50 to 74 years
and with more than a third (36%) diagnosed in those 75 years old or older.4 At older ages, sexual function also tends to de-
cline. For example, in the Massachusetts Male Ageing Study, which followed 1085 men aged 40 to 70 years for 9 years,
significant declines were observed in almost all domains of sexual function.5 A survey of 3005 middle-aged and older US
men and women (57-85 years) also found that the prevalence of sexual activity declined from 73% in those aged 57 to 64
years to 26% in those aged 75 to 85 years,6 and similar results have been reported in the Third National Survey of Sexual
Attitudes and Lifestyles (NATSAL3) in the United Kingdom, which was the first in this series of population studies to
include older adults.7,8 In the English Longitudinal Study of Ageing (ELSA), 76% of men and 53% of women older than
50 years reported being sexually active, and this indicates that sexual function is still an important aspect of life for a large
proportion of older adults.9
A number of studies have compared sexual function before and immediately after cancer treatment10,11 or compared
one treatment modality with another,12 and both types have shown differences. However, there is a need for studies that
include population-based control samples. The few case-control studies that have used validated assessments of sexual
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function have generally been performed in younger
groups, and results have been mixed. In a comparison of
246 testicular cancer survivors (80% of whom were 18-49
years old) and 236 ethnically matched and age-matched
controls using the Brief Male Sexual Function Inventory,
the cancer survivor group reported impaired ejaculation
and erection problems.13 However, a meta-analysis of 28
retrospective studies and 7 prospective studies between
1975 and 2000 reported no significant deterioration of
sexual function for testicular cancer survivors, although
the authors acknowledged methodological limitations in
many of the studies.14 As for women, in a US study of sex-
ual activity comparing 50 cervical cancer survivors (mean
age, 45.3 years) and 50 age-matched controls, cancer sur-
vivors reported less sexual interest, more sexual dysfunc-
tion, and less sexual satisfaction. However, no difference
in the frequency of sexual intercourse was recorded.15 A
study in Iran comparing 71 young breast cancer survivors
(mean age, 41.3 years) with 94 women without cancer
(mean age, 44.2 years) found no significant differences in
the prevalence of sexual dysfunction with the Female Sex-
ual Function Index.16
It is important to determine whether sexual prob-
lems experienced by older cancer survivors are significant-
ly different from those of older adults generally. One of
the few studies in the older age group compared survivors
of colon and rectal cancer (n5 1359) with cancer-free
controls (n5 400) and reported that male colorectal
cancer survivors were slightly less sexually active than
controls, whereas women reported lower enjoyment of
sex. Male rectal cancer survivors also had more erectile
and ejaculatory problems.17
The aim of the current study was, therefore, to add
to the evidence base through a comparison of sexual func-
tion in cancer survivors and cancer-free controls based on
data from a population-based sample of older adults in
the United Kingdom.
MATERIALS AND METHODS
Study Population
Data were drawn from wave 6 (2012-2013) of ELSA.
ELSA is a longitudinal panel study of aging, health, and
well-being among men and women aged 50 years or older
and living in private households in England.18 Of the
10,601 individuals who were interviewed in wave 6 of
ELSA, 7079 (67% of those eligible) completed the paper-
based questionnaire that included measures of sexual atti-
tudes and behavior. After the exclusion of 389 participants
(5.5%) due to missing data on cancer, our final sample
comprised 6690 men and women. All participants gave
full informed consent to participate in the study, and ethi-
cal approval was obtained from the London Multi-Centre
Research Ethics Committee.
Measures
Wave 6 of ELSA was the first to include questions on sex-
ual relationships and activities. The Sexual Relationships
and Activities Questionnaire (SRA-Q) includes items tak-
en from validated instruments,19-21 with minor modifica-
tions made to create versions specific for men (37 items)
and women (31 items). The male and female versions of
the SRA-Q are available online.22 Participants completed
the questionnaire in private and returned it in a sealed en-
velope. The SRA-Q captures a wide range of information
on attitudes to sex; the frequency of sexual activities and
behaviors; problems with sexual activities and function;
concerns and worries about sexual activities, sexual func-
tion, and relationships; and details about current sexual
partners and satisfaction. For the purpose of our analyses,
we focused on items related to sexual activities and behav-
ior, sexual functioning, and sexual concerns and satisfac-
tion, as summarized in Table 1.
Cancer diagnoses were assessed by the presentation
of a list of conditions that included cancer and the follow-
ing question: “Has a doctor ever told you that you have
(or have had) any of the conditions on this card?” Nonme-
lanoma skin cancers were excluded.
Demographic information used in the current analyses
included age, sex, partnership status (married/cohabiting, sep-
arated/divorced, widowed, or single/never married),
and nonpension wealth quintile (a sensitive indicator of
socioeconomic status in this population group23). Data on
participant-reported diagnoses of diabetes, coronary heart dis-
ease, arthritis, asthma, and chronic lung disease were also in-
cluded, and from these data, we created a comorbidity score
that indicated the number of these conditions (range, 0-5).
Statistical Analysis
We used weights to correct for sampling probabilities and
for differential nonresponse and to calibrate back to the
2011 national census population distributions for age and
sex. The weights accounted for the differential probability
of being included in wave 6 of ELSA and for nonresponse
to the SRA-Q. Details can be found online.24 Analyses
were conducted with IBM SPSS 19, with a P value< .05
indicating statistical significance.
Participants were categorized as those who reported
a diagnosis of cancer or as controls who had never been di-
agnosed with cancer. This was favored over a completely
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healthy control group because it enabled us to determine
the specific influence of a cancer diagnosis over and above
other chronic diseases (which both groups might have).
The 2 groups’ characteristics were compared with inde-
pendent t tests (continuous variables) and chi-square anal-
yses (categorical variables). Logistic regression was used to
test the odds of frequent sexual activities, difficulties with
sexual functioning, and sexual concerns in the cancer sur-
vivor group versus the control group. For each outcome,
age-adjusted percentages were examined with logistic re-
gression models; we adjusted them for sampling probabil-
ities and differential nonresponse and controlled for
comorbidities. We adjusted for age and comorbid health
conditions in light of the findings of a previous study in
this cohort, which revealed significantly lower levels of
sexual activity and poorer sexual functioning among par-
ticipants who were older and in poorer health.9 We did
not adjust for partnership status or wealth because the
groups did not differ significantly on these variables.
To examine whether differences between cancer
survivors and controls differed according to the time since
diagnosis, analyses were repeated with stratification by the
time since diagnosis (within the last 5 years vs more than 5
years earlier). The 5-year cutoff was selected because it is a
commonly used survival statistic.25 All analyses were per-
formed separately for women and men because there were
some differences in the male and female SRA-Q items,
and previous studies have observed notable sex differences
in sexual attitudes and behavior.6,8,9,26,27
RESULTS
There were 2982 men and 3708 women in the study; 220
of the men (7.4%) and 341 of the women (9.2%) had
been diagnosed with cancer. Among the cancer survivors,
430 (76.6%) had been diagnosed 5 years previously.
The mean time since diagnosis was 11.35 years (standard
deviation, 8.90 years), and the range was 2 to 57 years
(median, 9.0 years). In line with data from cancer
TABLE 1. Measures of Sexual Behavior, Function, and Concerns in the Sexual Relationships and Activities
Questionnaire of the English Longitudinal Study of Ageing
Itema Response Options Classification
Sexual behavior and activities (during the past month)
How often did you think about sex? 7-point scale: “not at all” to “more
than once a day”
Thinking about sex frequently:
“2-3 times a month” or more
How many times have you had or attempted sexual
intercourse (vaginal, anal, or oral)?
7-point scale: “not at all” to “more
than once a day”
Frequent sexual intercourse:
“2-3 times a month” or more
How frequently did you engage in other sexual
activities (kissing, petting, or fondling)?
7-point scale: “not at all” to “more
than once a day”
Frequent kissing, petting, or fondling:
“2-3 times a month” or more
Sexual function (during the past month)
Are you able to get or keep an erection which would
be good enough for sexual activity? [men]
4-point scale: “always able” to
“never able”
Erectile difficulties: “never able” or
“sometimes able”
How often did you feel sexually aroused during
sexual activity? [women]
5-point scale: “never” to “always” Difficulty becoming sexually aroused:
“never” or “much less than half the
time”
When you had sexual stimulation, how difficult was
it for you to reach orgasm?
5-point scale: “impossible” to
“not at all”
Difficulty achieving orgasm: “moderately
difficult” to “impossible”
Sexual concerns (during the past month)
Have you been worried or concerned by your
level of sexual desire?
5-point scale: “not at all worried or
concerned” to “extremely worried
or concerned”
Concerned about level of sexual desire:
“moderately,” “very,” or “extremely
worried or concerned”
Have you been worried or concerned by the frequency
of your sexual activities?
5-point scale: “not at all worried or
concerned” to “extremely worried
or concerned”
Concerned about frequency of sexual
activities: “moderately,” “very,” or
“extremely worried or concerned”
Have you been worried or concerned by your ability
to have an erection? [men]
5-point scale: “not at all worried or
concerned” to “extremely worried
or concerned”
Concerned about ability to have an
erection: “moderately,” “very,” or
“extremely worried or concerned”
Are you worried or concerned by your current ability
to become sexually aroused? [women]
5-point scale: “not at all worried or
concerned” to “extremely worried
or concerned”
Concerned about ability to become
sexually aroused: “moderately,” “very,”
or “extremely worried or concerned”
Have you been worried or concerned by
your orgasmic experience?
5-point scale: “not at all worried or
concerned” to “extremely worried
or concerned”
Concerned about orgasmic experience:
“moderately,” “very,” or “extremely
worried or concerned”
Sexual satisfaction (during the past three months)
How satisfied have you been with your overall sex life? 5-point scale: “very satisfied” to
“very dissatisfied”
Dissatisfied with overall sex life:
“moderately dissatisfied” or “very
dissatisfied”
a All items were asked of both men and women unless otherwise specified.
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registries,28 the most prevalent cancers in our sample were
breast cancer, prostate cancer, colorectal cancer, and
melanoma.
Characteristics of the cancer survivor and cancer-free
control groups are shown in Table 2. Cancer survivors
were significantly older than controls (71.1 vs 65.9 years
for men and 68.9 vs 65.2 years for women; P< .001 for
both), and they reported more comorbid conditions (0.92
vs 0.73 for men and 0.92 vs 0.77 for women; P5 .003 for
both). The groups did not differ significantly by partner-
ship status or wealth.
Tables 3 and 4 show the age-adjusted proportions of
women and men who reported engaging in sexual activity,
experiencing sexual difficulties, and having concerns
about their sex lives. Approximately half of the women in
both the cancer survivor and control groups reported fre-
quent sexual intercourse (49.1% vs 50.1%; odds ratio
[OR], 0.98; 95% confidence interval [CI], 0.70-1.38).
There were no differences in measures of sexual function
(difficulties in becoming sexually aroused in women and
erectile function in men). Women who had received a
cancer diagnosis were significantly more dissatisfied with
their sex lives than controls were (18.2% vs 11.8%; OR,
1.84; 95% CI, 1.05-3.25) and expressed more concerns
about their levels of sexual desire (10.2% vs 7.1%; OR,
1.83; 95% CI, 1.19-2.81; Table 3). Similar proportions
of men in the cancer survivor and control groups reported
being sexually active (76.0% vs 78.5%; OR, 0.93; 95%
CI, 0.66-1.31). As in the case of women, male cancer sur-
vivors reported being significantly more dissatisfied with
their sex lives than controls (30.9% vs 19.8%; OR, 1.74;
95% CI, 1.08-2.80). Independently of diagnosis, individ-
uals with a partner reported higher levels of sexual activity
than those without a partner.
Tables 5 and 6 show results stratified by the time
since diagnosis. Stratification according to the time since
diagnosis indicated that differences in sexual activity and
function with respect to controls were more pronounced
among female cancer survivors diagnosed within the last 5
years than those diagnosed more than 5 years earlier.
Levels of sexual activity did not differ, but women who
had been diagnosed within the past 5 years were more
likely to report difficulties with sexual function, with sig-
nificantly more survivors than controls reporting difficul-
ty in becoming sexually aroused (55.4% vs 31.8%; OR,
2.75; 95% CI, 1.21-6.26) and achieving orgasm (60.6%
vs 28.3%; OR, 4.72; 95% CI, 1.98-11.24). However,
these differences were not present in those diagnosed
more than 5 years ago, and only differences in satisfaction
with sex life was observed, with female cancer survivors
reporting lower overall satisfaction with their sex lives
(reporting dissatisfaction, 18.7% vs 11.8%; OR, 1.93;
95%CI, 1.03-3.61).
There were no significant differences in any aspect
of sexuality between male cancer survivors diagnosed less
than 5 years ago and male cancer-free controls. However,
the greater dissatisfaction with sex life reported in the
complete sample of male cancer survivors was limited to
men diagnosed more than 5 years ago (32.9% vs 19.8%;
OR, 1.92; 95%CI, 1.11-3.34).
TABLE 2. Characteristics of the Cancer Survivors and Controls
Men (n5 2982) Women (n53708)
Cancer Survivors Controls P Cancer Survivors Controls P
No. 220 2762 341 3367
Age, mean (SD), y 71.14 (8.09) 65.91 (8.68) <.001 68.87 (8.37) 65.18 (8.33) <.001
Partnership status, % (No.)
Married/cohabiting 80.0 (176) 77.0 (2126) .62 60.4 (206) 64.4 (2169) .41
Separated/divorced 9.1 (20) 9.7 (267) — 14.7 (50) 14.4 (484) —
Widowed 6.4 (14) 6.7 (184) — 19.1 (65) 16.5 (557) —
Single/never married 4.5 (10) 6.7 (185) — 5.9 (20) 4.7 (157) —
Wealth quintile, % (No.)
1 (poorest) 10.6 (23) 13.1 (317) .42 13.6 (46) 16.8 (494) .16
2 20.7 (45) 16.8 (405) — 16.3 (55) 19.9 (586) —
3 19.4 (42) 21.1 (510) — 22.2 (75) 20.9 (617) —
4 22.1 (48) 24.2 (583) — 25.1 (85) 21.2 (626) —
5 (richest) 27.2 (59) 24.8 (597) — 22.8 (77) 21.1 (623) —
No. of comorbidities, mean (SD) 0.92 (1.01) 0.73 (0.88) .003 0.92 (0.91) 0.77 (0.85) .003
Abbreviation: SD, standard deviation.
Numbers may not add up to the total because of missing data for some variables. Valid percentages are shown for ease of interpretation. Bolded P values are
significant.
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DISCUSSION
This is the first analysis of cohort data to compare sexual
behavior and concerns between cancer survivors and con-
trols from the same population-based study with a stan-
dardized measure. The main finding is that cancer
survivors do not differ from cancer-free controls in wheth-
er they are sexually active or in the frequency of different
types of sexual activity. In the shorter term (<5 years after
the diagnosis), female cancer survivors were more likely to
experience sexual dysfunction. However, more than 5
years after the diagnosis, the only significant difference
was that cancer survivors reported more dissatisfaction
with their sex lives. There were no differences between
male cancer survivors and controls in erectile difficulties
or problems achieving orgasm. These findings are impor-
tant because an extremely high proportion of cancer
patients will become long-term survivors, and a clear pic-
ture of life after cancer is required.
To our knowledge, just one other study has exam-
ined differences in sexual function in older cancer survi-
vors; it compared 1359 colorectal cancer survivors and a
small sample of age-matched controls.9 In this sample,
sexual function was reduced in both men and women in
the cancer survivor group. However, in men, there was no
significant difference in sexual enjoyment. The time since
diagnosis was not reported in this study,17 and the use of a
small normative population was a limitation. However, it
is likely that the nature of treatments for certain cancers
(eg, colorectal, prostate, or gynecological cancers) has a
more significant impact on sexual function in the short
term.
Our results show less striking differences between
cancer survivors and controls than some previous stud-
ies.10-13,15 This might be due to 2 factors. First, the focus
of much previous research has been on younger survivors,
who are in such a minority and among whom concerns re-
lated to sexuality may differ (eg, reproductive issues).
Because cancer is a disease that occurs predominantly at
older ages, the results of these studies may not be general-
izable to older cancer survivors. Our study focused on
those older than 50 years, who receive more than 90% of
the cancer diagnoses in the UK population4; data were
drawn from a population-based cohort known to be
broadly representative of this age group.18 Second, in
TABLE 3. Sexual Activities, Functioning, and Concerns in Cancer Survivors and Controls: Women
Controls/Cancer
Survivors, No.
Age-Adjusted Percentages
Adjusted
OR (95% CI) PControls
Cancer
Survivors
Sexual activity and behavior
Any sexual activity in the past year
All 3367/341 55.5 58.2 1.17 (0.90-1.54) .24
Living with a partner 2313/222 71.1 69.8 0.96 (0.68-1.35) .81
Not living with a partner 1054/119 25.0 30.4 1.48 (0.86-2.56) .16
Thinking about sex frequently 3332/339 47.2 50.8 1.17 (0.89-1.54) .25
Frequent sexual intercoursea
All 1915/170 50.1 49.1 0.98 (0.70-1.38) .91
Living with a partner 1625/143 52.6 52.1 0.99 (0.68-1.43) .94
Not living with a partner 290/27 36.6 30.2 0.83 (0.31-2.25) .71
Frequent kissing, petting, or fondlinga
All 1914/171 67.8 69.0 0.95 (0.67-1.36) .78
Living with a partner 1625/144 72.3 74.2 0.98 (0.65-1.47) .91
Not living with a partner 289/27 42.9 37.9 0.67 (0.26-1.74) .41
Sexual function
Difficulty becoming sexually arousedb 1392/116 31.8 31.4 0.95 (0.61-1.47) .81
Difficulty achieving orgasmb 1332/109 28.3 29.3 1.13 (0.73-1.77) .58
Sexual health concerns and satisfaction
Concerned about . . .
Level of sexual desire 3342/340 7.1 10.2 1.83 (1.19-2.81) .006
Frequency of sexual activitiesa 1926/171 8.0 5.4 0.57 (0.25-1.28) .17
Ability to become sexually arousedb 1384/115 7.6 6.4 0.76 (0.33-1.76) .52
Orgasmic experienceb 1333/110 7.1 10.4 1.53 (0.77-3.03) .22
Dissatisfied with overall sex lifea 1419/108 11.8 18.2 1.84 (1.05-3.25) .034
Abbreviations: CI, confidence interval; OR odds ratio.
The ORs are for the cancer group versus the controls (the reference group), and they have been adjusted for age and comorbidities. All analyses have been
weighted for sampling probabilities and differential nonresponse. Bolded P values are significant.
a In participants reporting any sexual activity in the past year.
b In participants reporting any sexual activity in the past month.
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some previous studies, there has been an absence of age-
relevant comparison groups. Because levels of sexual activ-
ity decline with age, cancer survivors may attribute any
changes to their health condition rather than the passage
of time. Our study suggested that in longer term survivor-
ship, there are few differences between cancer survivors
and controls. It may be that aging causes controls to
“catch up” to cancer survivors in terms of sexuality.
Cancer survivors may experience an accelerated decline in
sexuality around the time of diagnosis, whereas changes
happen more gradually over time in individuals who re-
main cancer-free, but it seems that both groups ultimately
reach similar levels of sexual activity and functioning. To
extend the existing literature, future research should ex-
amine differences between specific cancer sites and age-
matched controls in older adults and include long-term
follow-up.
Although we found few differences in long-term
cancer survivors, women in our study who were diagnosed
<5 years ago reported more sexual dysfunction. In a re-
cent large qualitative study of 1514 cancer survivors with
mixed sites, physical symptoms (including sexual dysfunc-
tion) were the most commonly reported unmet care needs
(38.2% of the participants). Interestingly, in this study,
older cancer survivors were more likely than younger par-
ticipants to report unmet needs in the physical domain.28
Our results suggest that a large proportion of cancer survi-
vors remain sexually active, whether they live with part-
ners or not, so addressing aspects of sexual dysfunction
(particularly in women soon after their diagnosis) is
important.
Our study indicated that long-term cancer survivors
were less satisfied with their sex lives, despite levels of
arousal, sexual activity, and sexual function broadly simi-
lar to those of controls. There is currently a lack of evi-
dence showing that older cancer survivors do dramatically
differ in terms of sexual function. However, the reasons
behind the significantly lower satisfaction with sex lives
reported by both male and female cancer survivors in our
study are an area for further research because this may di-
rect the development and nature of rehabilitation pack-
ages. There is a need to develop such packages to arm
clinicians with the tools to address sexual function after
cancer treatment. In a qualitative study, colorectal cancer
TABLE 4. Sexual Activities, Functioning, and Concerns in Cancer Survivors and Controls: Men
Controls/Cancer
Survivors, No.
Age-Adjusted Percentages
Adjusted
OR (95% CI) PControls
Cancer
Survivors
Sexual activity and behavior
Any sexual activity in the past year
All 2762/220 78.5 76.0 0.93 (0.66-1.31) .67
Living with a partner 2254/182 81.4 77.0 0.81 (0.55-1.20) .29
Not living with a partner 508/38 68.5 70.2 1.35 (0.62-2.97) .45
Thinking about sex frequently 2749/217 81.3 76.3 0.79 (0.56-1.11) .18
Frequent sexual intercoursea
All 2137/138 48.0 49.0 1.18 (0.81-1.70) .39
Living with a partner 1796/116 51.0 52.7 1.21 (0.81-1.82) .35
Not living with a partner 341/22 35.6 27.7 0.79 (0.28-2.24) .66
Frequent kissing, petting, or fondlinga
All 2139/138 63.7 68.1 1.20 (0.83-1.74) .33
Living with a partner 1799/116 68.5 74.0 1.29 (0.84-1.96) .25
Not living with a partner 340/22 43.4 31.9 0.62 (0.23-1.70) .36
Sexual function
Erectile difficulties 2724/217 39.3 40.3 0.97 (0.69-1.35) .84
Difficulty achieving orgasmb 1536/92 13.5 13.2 0.91 (0.51-1.65) .76
Sexual health concerns and satisfaction
Concerned about . . .
Level of sexual desire 2758/218 13.9 11.1 0.70 (0.43-1.13) .14
Frequency of sexual activitiesa 2147/139 13.1 15.7 1.17 (0.72-1.91) .53
Ability to have an erection 2747/219 13.2 14.0 1.03 (0.68-1.54) .90
Orgasmic experienceb 1520/90 10.6 11.4 0.92 (0.47-1.79) .80
Dissatisfied with overall sex lifea 1442/85 19.8 30.9 1.74 (1.08-2.80) .023
Abbreviations: CI, confidence interval; OR odds ratio.
The ORs are for the cancer group versus the controls (the reference group), and they have been adjusted for age and comorbidities. All analyses have been
weighted for sampling probabilities and differential nonresponse. Bolded P values are significant.
a In participants reporting any sexual activity in the past year.
b In participants reporting any sexual activity in the past month.
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TABLE 5. Differences in Self-Reported Sexual Activities, Functioning, and Concerns in Cancer Survivors Di-
agnosed Within the Last 5 Years and Cancer Survivors Diagnosed More Than 5 Years Ago in Comparison
With Controls: Women
Controls
(n5 3367), %a
Cancer Survivors
Diagnosed<5 y Ago (n563)
Cancer Survivors
Diagnosed5 y Ago (n5 278)
%a Adjusted OR (95% CI) P %a Adjusted OR (95% CI) P
Sexual activity and behavior
Any sexual activity in the past year
All 55.5 61.0 1.11 (0.62-1.97) .73 57.5 1.19 (0.89-1.61) .25
Living with a partner 71.1 70.9 0.83 (0.42-1.61) .58 69.4 1.00 (0.68-1.47) .99
Not living with a partner 25.0 27.9 0.92 (0.18-4.58) .91 30.8 1.58 (0.89-2.80) .12
Thinking about sex frequently 47.2 48.2 0.90 (0.49-1.63) .72 51.5 1.25 (0.93-1.69) .15
Frequent sexual intercourseb 50.1 46.8 1.01 (0.49-2.06) .98 49.8 0.97 (0.66-1.43) .89
Frequent kissing, petting, or fondlingb 67.8 60.1 0.65 (0.32-1.33) .24 71.6 1.06 (0.71-1.58) .78
Sexual function
Difficulty becoming sexually arousedc 31.8 55.4 2.75 (1.21-6.26) .016 23.5 0.63 (0.37-1.09) .097
Difficulty achieving orgasmc 28.3 60.6 4.72 (1.98-11.24) <.001 19.1 0.65 (0.37-1.16) .14
Sexual health concerns and satisfaction
Concerned about . . .
Level of sexual desire 7.1 14.8 2.84 (1.34-6.04) .007 9.1 1.57 (0.94-2.60) .083
Frequency of sexual activitiesb 8.0 3.4 0.65 (0.12-3.47) .62 6.0 0.54 (0.22-1.37) .20
Ability to become sexually arousedc 7.6 6.3 0.85 (0.17-4.14) .84 6.4 0.73 (0.28-1.93) .53
Orgasmic experiencec 7.1 17.6 3.05 (1.04-8.93) .042 8.0 1.13 (0.48-2.67) .77
Dissatisfied with overall sex lifeb 11.8 16.5 1.55 (0.46-5.22) .48 18.7 1.93 (1.03-3.61) .039
Abbreviations: CI, confidence interval; OR odds ratio.
The ORs are for the cancer survivors versus the controls (the reference group), and they have been adjusted for age and comorbidities. All analyses have
been weighted for sampling probabilities and differential nonresponse. Bolded P values are significant.
a Adjusted for age.
b In participants reporting any sexual activity in the past year.
c In participants reporting any sexual activity in the past month.
TABLE 6. Differences in Self-Reported Sexual Activities, Functioning, and Concerns in Cancer Survivors Di-
agnosed Within the Last 5 Years and Cancer Survivors Diagnosed More Than 5 Years Ago in Comparison
With Controls: Men
Controls
(n5 2762), %a
Cancer Survivors
Diagnosed<5 y Ago (n5 68)
Cancer Survivors
Diagnosed5 y Ago (n5 152)
%a Adjusted OR (95% CI) P %a Adjusted OR (95% CI) P
Sexual activity and behavior
Any sexual activity in the past year
All 78.5 74.3 0.81 (0.44-1.50) .50 76.7 0.98 (0.65-1.47) .92
Living with a partner 81.4 73.3 0.59 (0.30-1.17) .13 78.7 0.92 (0.58-1.45) .72
Not living with a partner 68.5 79.5 2.11 (0.51-8.74) .31 66.0 1.11 (0.44-2.81) .82
Thinking about sex frequently 81.3 73.6 0.66 (0.36-1.21) .18 77.5 0.85 (0.56-1.27) .42
Frequent sexual intercourseb 48.0 39.5 0.77 (0.40-1.47) .42 53.4 1.44 (0.92-2.23) .11
Frequent kissing, petting, or fondlingb 63.7 76.9 1.85 (0.92-3.73) .087 64.1 1.01 (0.65-1.55) .98
Sexual function
Erectile difficulties 39.3 38.3 0.87 (0.48-1.55) .63 41.2 1.01 (0.68-1.52) .95
Difficulty achieving orgasmc 13.5 18.3 1.27 (0.48-3.39) .63 10.7 0.78 (0.38-1.61) .51
Sexual health concerns and satisfaction
Concerned about . . .
Level of sexual desire 13.9 11.3 0.68 (0.29-1.56) .36 11.0 0.71 (0.40-1.25) .24
Frequency of sexual activitiesb 13.1 20.5 1.89 (0.91-3.89) .090 13.5 0.87 (0.46-1.67) .68
Ability to have an erection 13.2 17.2 1.35 (0.70-2.60) .38 12.6 0.90 (0.54-1.48) .67
Orgasmic experiencec 10.6 11.1 0.90 (0.27-3.00) .87 11.5 0.92 (0.42-2.02) .84
Dissatisfied with overall sex lifeb 19.8 26.3 1.34 (0.55-3.28) .53 32.9 1.92 (1.11-3.34) .020
Abbreviations: CI, confidence interval; OR odds ratio.
The ORs are for the cancer survivors versus the controls (the reference group), and they have been adjusted for age and comorbidities. All analyses have
been weighted for sampling probabilities and differential nonresponse. Bolded P values are significant.
a Adjusted for age.
b In participants reporting any sexual activity in the past year.
c In participants reporting any sexual activity in the past month.
survivors and their partners both emphasized the impor-
tance of receiving sexual health care and the need to be in-
formed about treatment options for any problems with
sexual function that could arise.3 However, in clinical
consultations, they had not felt able to raise the issue of
sexual health because they saw it as a side issue to the main
focus of clinical consultations: survival. In the same study,
health professionals reported similar concerns about the
appropriateness of discussing sex when survival was the
primary concern, and they hesitated to raise the issue for
fear of making patients and their partners feel uncomfort-
able. In some cases, health professionals reported feeling
that discussing sex would be irrelevant, particularly if
patients were older, female, or single.3 However, data
from NATSAL3 and from the current study suggest that
such assumptions are not necessarily correct.7
This study benefited from a detailed standard mea-
sure of sexual functioning and the availability of informa-
tion on comorbid health conditions as well as a control
population recruited on a similar basis. However, there
were a number of limitations. Cancer data were self-
reported, but previous studies have shown high agreement
between self-reported cancer diagnoses and medical re-
cord validation in population-based samples.29-31 The
sample of cancer survivors was not large enough for an
analysis by cancer site, and there may be differences be-
tween sites. We did not have detailed information on the
date of diagnosis (or the type of treatment). Sensitivity
analyses in which cancer survivors were stratified by the
time since diagnosis suggested that differences were more
pronounced among those diagnosed within the last 5
years, but small sample sizes meant that these analyses
lacked statistical power. We performed a large number of
statistical tests, and it is possible that adjustments for mul-
tiple comparisons might reduce the number of significant
findings.
In conclusion, on the whole, our results are generally
encouraging: they show that older people with cancer do
not experience greater problems with sexual activity or
functioning than age-matched, cancer-free controls. A di-
agnosis of cancer does not seem to affect whether or not
people have sex, how often they have sex, what they do
when they have sex, and (in the case of men) their sexual
function. Compared with age-matched controls, women
who had been diagnosed with cancer within the past 5
years were just as likely to be sexually active, although they
were more likely to report problems with arousal.
Following the 5 years after the diagnosis, the only differ-
ence was greater dissatisfaction with their sex lives. Male
survivors did not report any more significant sexual prob-
lems than their age-matched counterparts, but they were
more dissatisfied with their sex lives.
Further research is required to address sexual diffi-
culties in women in the immediate postdiagnosis phase.
There is currently very little available to help women deal
with low sexual desire. This is especially the case if they
have a history of certain breast cancers or certain gyneco-
logical cancers and in light of the fact that systemic hor-
mone replacement therapy is generally not recommended
in women, regardless of their cancer history.
Future studies should also seek to establish why dis-
satisfaction with one’s sex life is higher among long-term
cancer survivors even though their sexual function is simi-
lar to that of the general population. On the basis of the
results of the current study and other studies in both can-
cer survivors and the general population, it is evident that
there is a need to identify interventions to enhance sexual
health in aging men and women. In the meantime, better
advice on normal changes in sexual activity and function-
ing with aging could help to address the discrepancy be-
tween normative sexual behavior and lower sexual
satisfaction in cancer survivors.
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